Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response
Abstract. Lung cancer is one of the leading causes of all cancer-related deaths. Circulating tumor DNA (ctDNA) is released from apoptotic and necrotic tumor cells. Several sensitive techniques have been invented and adapted to quantify ctDNA genomic alterations. Applications of ctDNA in lung cancer...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2020-10-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000001097 |
| _version_ | 1818648169399975936 |
|---|---|
| author | Rui-Yu Li Zhi-Yong Liang Pei-Fang Wei. |
| author_facet | Rui-Yu Li Zhi-Yong Liang Pei-Fang Wei. |
| author_sort | Rui-Yu Li |
| collection | DOAJ |
| description | Abstract. Lung cancer is one of the leading causes of all cancer-related deaths. Circulating tumor DNA (ctDNA) is released from apoptotic and necrotic tumor cells. Several sensitive techniques have been invented and adapted to quantify ctDNA genomic alterations. Applications of ctDNA in lung cancer include early diagnosis and detection, prognosis prediction, detecting mutations and structural alterations, minimal residual disease, tumor mutational burden, and tumor evolution tracking. Compared to surgical biopsy and radiographic imaging, the advantages of ctDNA are that it is a non-invasive procedure, allows real-time monitoring, and has relatively high sensitivity and specificity. Given the massive research on non-small cell lung cancer, attention should be paid to small cell lung cancer. |
| first_indexed | 2024-12-17T01:14:09Z |
| format | Article |
| id | doaj.art-aedabe9d9a334deaaa499c5c4881e97e |
| institution | Directory Open Access Journal |
| issn | 0366-6999 2542-5641 |
| language | English |
| last_indexed | 2024-12-17T01:14:09Z |
| publishDate | 2020-10-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj.art-aedabe9d9a334deaaa499c5c4881e97e2022-12-21T22:09:04ZengWolters KluwerChinese Medical Journal0366-69992542-56412020-10-01133202476248510.1097/CM9.0000000000001097202010200-00013Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment responseRui-Yu Li0Zhi-Yong Liang1Pei-Fang Wei.2Department of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.Department of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.Department of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.Abstract. Lung cancer is one of the leading causes of all cancer-related deaths. Circulating tumor DNA (ctDNA) is released from apoptotic and necrotic tumor cells. Several sensitive techniques have been invented and adapted to quantify ctDNA genomic alterations. Applications of ctDNA in lung cancer include early diagnosis and detection, prognosis prediction, detecting mutations and structural alterations, minimal residual disease, tumor mutational burden, and tumor evolution tracking. Compared to surgical biopsy and radiographic imaging, the advantages of ctDNA are that it is a non-invasive procedure, allows real-time monitoring, and has relatively high sensitivity and specificity. Given the massive research on non-small cell lung cancer, attention should be paid to small cell lung cancer.http://journals.lww.com/10.1097/CM9.0000000000001097 |
| spellingShingle | Rui-Yu Li Zhi-Yong Liang Pei-Fang Wei. Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response Chinese Medical Journal |
| title | Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response |
| title_full | Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response |
| title_fullStr | Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response |
| title_full_unstemmed | Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response |
| title_short | Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response |
| title_sort | circulating tumor dna in lung cancer real time monitoring of disease evolution and treatment response |
| url | http://journals.lww.com/10.1097/CM9.0000000000001097 |
| work_keys_str_mv | AT ruiyuli circulatingtumordnainlungcancerrealtimemonitoringofdiseaseevolutionandtreatmentresponse AT zhiyongliang circulatingtumordnainlungcancerrealtimemonitoringofdiseaseevolutionandtreatmentresponse AT peifangwei circulatingtumordnainlungcancerrealtimemonitoringofdiseaseevolutionandtreatmentresponse |